silybin has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, TL; Tao, ZS; Wang, HS; Wei, S | 1 |
| Gao, M; Hayashi, T; Ikeda, K; Ikejima, T; Li, D; Negishi, H; Sun, Y; Xu, F; Yang, J; Zhang, X | 1 |
2 other study(ies) available for silybin and Hyperglycemia
| Article | Year |
|---|---|
Silibinin-modified Hydroxyapatite coating promotes the osseointegration of titanium rods by activation SIRT1/SOD2 signaling pathway in diabetic rats.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Experimental; Durapatite; Hyperglycemia; Osseointegration; Osteoblasts; Osteogenesis; Rats; Reactive Oxygen Species; Signal Transduction; Silybin; Sirtuin 1; Superoxide Dismutase; Titanium | 2022 |
Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats.
Topics: Animals; Brain; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Supplements; Duodenum; Gastrointestinal Tract; Glucagon-Like Peptide-1 Receptor; Gluconeogenesis; Hyperglycemia; Hypoglycemic Agents; Liver; Liver Glycogen; Male; Neurons; Obesity; Rats, Sprague-Dawley; Rats, Zucker; Silybin; Solitary Nucleus; Specific Pathogen-Free Organisms; Vagotomy | 2018 |